Champlain Investment Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
|
|||||
2023
Q2 | $97.3M | Buy |
|
|||||
2023
Q1 | $104M | Sell |
|
|||||
2022
Q4 | $92M | Sell |
|
|||||
2022
Q3 | $93.3M | Sell |
|
|||||
2022
Q2 | $113M | Sell |
|
|||||
2022
Q1 | $138M | Sell |
|
|||||
2021
Q4 | $185M | Sell |
|
|||||
2021
Q3 | $187M | Sell |
|
|||||
2021
Q2 | $168M | Buy |
|
|||||
2021
Q1 | $148M | Buy |
|
|||||
2020
Q4 | $136M | Buy |
|
|||||
2020
Q3 | $107M | Buy |
|
|||||
2020
Q2 | $91.3M | Buy |
|
|||||
2020
Q1 | $36M | Buy |
|
|||||
2015
Q1 | – | Sell |
|
|||||
2014
Q4 | $13.1M | Sell |
|
|||||
2014
Q3 | $79.7M | Sell |
|
|||||
2014
Q2 | $98.9M | Buy |
|
|||||
2014
Q1 | $102M | Buy |
|
|||||
2013
Q4 | $96.7M | Sell |
|
|||||
2013
Q3 | $92.2M | Buy |
|
|||||
2013
Q2 | $83.2M | Buy |
|